Aspergillus fumigatus
Aspergillus fumigatus is a species of fungus in the genus Aspergillus, and is one of the most common Aspergillus species to cause disease in individuals with an immunodeficiency.
Taxonomy[edit]
Aspergillus fumigatus was first described by the German mycologist Friedrich Wilhelm Gottlieb Rostkovius in 1808. It is a member of the genus Aspergillus, which includes over 200 species.
Morphology[edit]
Aspergillus fumigatus is a saprophytic fungus that plays a major role in recycling environmental carbon and nitrogen. Its spores are ubiquitous in the atmosphere and are commonly inhaled, though they rarely cause disease in healthy individuals.
Pathogenicity[edit]
Aspergillus fumigatus is an opportunistic pathogen and can cause a variety of diseases in humans, the most common of which is invasive aspergillosis. This disease primarily affects individuals with a compromised immune system, such as those with HIV/AIDS, those undergoing chemotherapy, or organ transplant recipients.
Treatment[edit]
Treatment for diseases caused by Aspergillus fumigatus typically involves antifungal medications. The choice of medication can depend on a variety of factors, including the specific disease, the patient's overall health, and the patient's response to treatment.
See also[edit]
-
Aspergillus fumigatus
-
Invasive Disease Mechanism Diagram
-
Aspergillus fumigatus
-
Secondary Metabolite Regulation by LaeA
-
Aspergillus fumigatus
-
Conidia phialoconidia of Aspergillus fumigatus
-
Aspergillus fumigatus
-
Aspergillus fumigatus
-
Aspergillus fumigatus
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
